Molecular Medicine Tri-Conference Asia will present three focused conferences presenting the most significant advances in research and technology in the areas of antibody engineering, clinical trial management and molecular diagnostics.

Bio-IT World Asia 2013 Conference will bring together, life sciences, pharmaceutical, informatics and IT professionals from all over Asia and the rest of the world to one unique location.

Molecular Medicine Tri-Conference Asia will present three focused conferences presenting the most significant advances in research and technology in the areas of antibody engineering, clinical trial management and molecular diagnostics.

In these presentations selected from the Strategies for Companion Diagnostic Development workshop at the Fourth Annual ADAPT Congress 2012, global IVD leaders and experienced consultants address the potential downstream effects of early decisions in the development cycle of companion diagnostics, what are the strategies to achieve successful commercialization of IVD products, how collaborative partnerships drive results and are models for successful development, and when and how a companion diagnostic should be included in drug trials.

Presentations selected from the Clinical Assay Development workshop at the Fourth Annual ADAPT Congress 2012 discuss how discovery and research assays are increasingly being converted into clinically useful assays that are used in clinical trials to improve patient outcome and to support drug development. Regulatory issues and the dedication of resources to develop assays are addressed, as well as strategies to overcome the challenges of using commercial assays on clinical samples; analytical validation studies to determine clinical utility; and the benefits of working with a diagnostics organization with both experienced IVD manufacturing and an extensive CLIA laboratory infrastructure.

Genomic technologies hold the potential to improve diagnosis and treatment of inherited disease and cancer, as well as the move towards personalized medicine. However, genomic data is complex and is not well integrated with software systems to support existing diagnostics, such as anatomic pathology and clinical pathology reporting systems needed for integrated diagnostics.